Search research articles
Contact Us
Filters
Showing results (211-220 of 229) with videos related to
Page
of 23
Sort By:
Journal of Hematology & Oncology
|
April 26, 2026
Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2
Javier Muñoz, Frederick L Locke, Patrick M Reagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Michael Wang, Javier Munoz, Andre Goy, et al.
Blood Advances
|
December 3, 2025
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop
Reid W Merryman, Sarah C Rutherford, Stephen M Ansell, et al.
Cancer Discovery
|
November 23, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Sarah M Larson, Christopher M Walthers, Brenda Ji, et al.
The New England Journal of Medicine
|
April 4, 2020
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang, Javier Munoz, Andre Goy, et al.
Bone Marrow Transplantation
|
January 4, 2024
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids
Olalekan O Oluwole, Edouard Forcade, Javier Muñoz, et al.
British Journal of Haematology
|
July 23, 2021
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma
Olalekan O Oluwole, Krimo Bouabdallah, Javier Muñoz, et al.
Lancet (London, England)
|
February 19, 2008
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Marc Gh Besselink, Hjalmar C van Santvoort, Erik Buskens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2013
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial
Philippe Armand, Arnon Nagler, Edie A Weller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma
Ronald Levy, Kristen N Ganjoo, John P Leonard, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 229) with videos related to
Sort By:
Page
of 23
Journal of Hematology & Oncology
|
April 26, 2026
Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2
Javier Muñoz, Frederick L Locke, Patrick M Reagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Michael Wang, Javier Munoz, Andre Goy, et al.
Blood Advances
|
December 3, 2025
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop
Reid W Merryman, Sarah C Rutherford, Stephen M Ansell, et al.
Cancer Discovery
|
November 23, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Sarah M Larson, Christopher M Walthers, Brenda Ji, et al.
The New England Journal of Medicine
|
April 4, 2020
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang, Javier Munoz, Andre Goy, et al.
Bone Marrow Transplantation
|
January 4, 2024
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids
Olalekan O Oluwole, Edouard Forcade, Javier Muñoz, et al.
British Journal of Haematology
|
July 23, 2021
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma
Olalekan O Oluwole, Krimo Bouabdallah, Javier Muñoz, et al.
Lancet (London, England)
|
February 19, 2008
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Marc Gh Besselink, Hjalmar C van Santvoort, Erik Buskens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2013
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial
Philippe Armand, Arnon Nagler, Edie A Weller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma
Ronald Levy, Kristen N Ganjoo, John P Leonard, et al.
Page
of 23